Latest & greatest articles for mammography

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on mammography or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on mammography and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for mammography

141. Comparison of screening mammography in the United States and the United kingdom. Full Text available with Trip Pro

Comparison of screening mammography in the United States and the United kingdom. Screening mammography differs between the United States and the United Kingdom; a direct comparison may suggest methods to improve the practice.To compare screening mammography performance between the United States and the United Kingdom among similar-aged women.Women aged 50 years or older were identified who underwent 5.5 million mammograms from January 1, 1996, to December 31, 1999, within 3 large-scale (...) mammography registries or screening programs: the Breast Cancer Surveillance Consortium (BCSC, n = 978 591) and National Breast and Cervical Cancer Early Detection Program (NBCCEDP, n = 613 388) in the United States; and the National Health Service Breast Screening Program (NHSBSP, n = 3.94 million) in the United Kingdom. A total of 27 612 women were diagnosed with breast cancer (invasive or ductal carcinoma in situ) within 12 months of screening among the 3 groups.Recall rates (recommendation for further

2003 JAMA

142. Evaluation of abnormal mammography results and palpable breast abnormalities. (Abstract)

Evaluation of abnormal mammography results and palpable breast abnormalities. Because approximately 1 in 10 women with a breast lump or abnormal mammography result will have breast cancer, a series of decisions must be taken by a primary care practitioner to exclude or establish a diagnosis of breast cancer among these women.To determine the most accurate and least invasive means to evaluate an abnormal mammography result and a palpable breast abnormality.MEDLINE search (January 1966 to March (...) 2003) for articles and reviews describing the accuracy of clinical examination, biopsy procedures, and radiographic examination for patients with abnormal mammography results or palpable breast abnormalities.The authors reviewed abstracts and selected articles that provided relevant primary data. Studies were included if 1) mammography, fine-needle aspiration biopsy, or core-needle biopsy was performed before a definitive diagnosis was obtained; 2) the study sample included 100 or more women; and 3

2003 Annals of Internal Medicine

143. Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. (Abstract)

Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. The long term effect of mammographic service screening is not well established. We aimed to assess the long-term effect of mammographic screening on death from breast cancer, taking into account potential biases from self-selection, changes in breast cancer incidence, and classification of cause of death.We compared deaths from breast cancer diagnosed in the 20 (...) ) but not in unscreened women (p=0.2). In both 40-69-year and 40-49-year age-groups, reductions in deaths from all cancers and from all-causes in women with breast cancer were consistent with these results.Taking account of potential biases, changes in clinical practice and changes in the incidence of breast cancer, mammography screening is contributing to substantial reductions in breast cancer mortality in these two Swedish counties.

2003 Lancet

144. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. (Abstract)

Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. The relationships among breast density, age, and use of hormone replacement therapy (HRT) in breast cancer detection have not been fully evaluated.To determine how breast density, age, and use of HRT individually and in combination affect the accuracy of screening mammography.Prospective cohort study.7 population-based mammography registries in North Carolina (...) are important predictors of the accuracy of screening mammography. Although HRT use is not an independent predictor of accuracy, it probably affects accuracy by increasing breast density.

2003 Annals of Internal Medicine

145. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. Full Text available with Trip Pro

Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial. The Women's Health Initiative trial of combined estrogen plus progestin was stopped early when overall health risks, including invasive breast cancer, exceeded benefits. Outstanding issues not previously addressed include characteristics of breast cancers observed among women using hormones and whether diagnosis may be influenced by hormone (...) effects on mammography.To determine the relationship among estrogen plus progestin use, breast cancer characteristics, and mammography recommendations.Following a comprehensive breast cancer risk assessment, 16 608 postmenopausal women aged 50 to 79 years with an intact uterus were randomly assigned to receive combined conjugated equine estrogens (0.625 mg/d) plus medroxyprogesterone acetate (2.5 mg/d) or placebo from 1993 to 1998 at 40 clinical centers. Screening mammography and clinical breast

2003 JAMA Controlled trial quality: predicted high

146. The cost effectiveness of 5 interventions to increase mammography adherence in a managed care population

The cost effectiveness of 5 interventions to increase mammography adherence in a managed care population The cost effectiveness of 5 interventions to increase mammography adherence in a managed care population The cost effectiveness of 5 interventions to increase mammography adherence in a managed care population Saywell R M, Champion V L, Zollinger T W, Maraj M, Skinner C S, Zoppi K A, Muegge C M Record Status This is a critical abstract of an economic evaluation that meets the criteria (...) for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Five strategies to improve mammography adherence were examined. These were: telephone counselling, in-person counselling, physician reminder letter, telephone counselling plus physician reminder letter, and in-person counselling plus physician reminder letter. Type of intervention

2003 NHS Economic Evaluation Database.

147. Regular mammography use is associated with elimination of age-related disparities in size and stage of breast cancer at diagnosis. (Abstract)

Regular mammography use is associated with elimination of age-related disparities in size and stage of breast cancer at diagnosis. There is little consensus about recommending mammography for women 75 years of age and older. These women have mammography less frequently and are more likely to receive a diagnosis of advanced breast cancer.To examine the relationship between use of screening mammography and size and stage of cancer at diagnosis in older women.Retrospective cohort study.Tumor (...) mammography than younger women (69 to 74 years of age). The association between increased mammography use and smaller tumor size and stage was significantly greater in older women than in younger women (P = 0.010 for stage; P = 0.001 for size). The percentage of regular mammography users who received a diagnosis of high-stage disease (28% vs. 26%; P > 0.2) and the mean size of the tumors (15.0 mm vs. 15.1 mm; P > 0.2) did not significantly differ between younger and older women, respectively

2002 Annals of Internal Medicine

148. News media coverage of screening mammography for women in their 40s and tamoxifen for primary prevention of breast cancer. (Abstract)

News media coverage of screening mammography for women in their 40s and tamoxifen for primary prevention of breast cancer. In the late 1990s, 3 events pertaining to breast cancer prevention received considerable attention in the US news media: a National Institutes of Health (NIH) consensus panel recommended against routine screening mammography for women in their 40s (January 1997), the National Cancer Institute (NCI) subsequently reversed the recommendation (March 1997), and an NCI-sponsored (...) ), and none left the impression that women should definitely take the drug (24% suggested they probably should). Sixty-five percent of these stories suggested that women faced a genuine choice and would have to weigh the risks and benefits themselves.Most news stories favored routine use of screening mammography and urged caution about using tamoxifen. Almost all noted the potential harms of each preventive strategy; however, the negative aspects of tamoxifen received greater emphasis. Whereas taking

2002 JAMA

149. Analysis of the cost-effectiveness of mammography promotion by volunteers in rural communities

Analysis of the cost-effectiveness of mammography promotion by volunteers in rural communities Analysis of the cost-effectiveness of mammography promotion by volunteers in rural communities Analysis of the cost-effectiveness of mammography promotion by volunteers in rural communities Andersen M R, Hager M, Su C, Urban N Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods (...) , the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The study investigated three different intervention strategies to promote mammography uptake by women in rural areas. The strategies were: individual counselling (IC), which included barrier-specific telephone counselling; community activities (CA), which included video presentations, themed bingo games, poster display, community newsletters and promotional

2002 NHS Economic Evaluation Database.

150. Mammography screening

Mammography screening Mammography screening Mammography screening Morland B, Lund Haheim L, Linnestad K Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Morland B, Lund Haheim L, Linnestad K. Mammography screening. Oslo: The Norwegian Knowledge Centre for the Health Services (NOKC) 2002 Authors' objectives This report aims to assess (...) the available evidence on the benefits of mammography screening. Authors' conclusions - Mammography screening in the age group of 50-69 years reduces breast cancer mortality. - The scientific documentation has some weaknesses and the estimated relative risk of reduction in mortality is in the order of 6% to 27%. Other documentation reports a risk reduction of 20-25%. - The effect in the age group 40-49 years is less and uncertain with an even weaker evidence. - Mammography screening does not protect against

2002 Health Technology Assessment (HTA) Database.

151. Digital mammography versus film-screen mammography: technical, clinical and economic assessments

Digital mammography versus film-screen mammography: technical, clinical and economic assessments Digital mammography versus film-screen mammography: technical, clinical and economic assessments Digital mammography versus film-screen mammography: technical, clinical and economic assessments Ho C, Hailey D, Warburton R, MacGregor J, Pisano E, Joyce J Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality (...) of this assessment has been made for the HTA database. Citation Ho C, Hailey D, Warburton R, MacGregor J, Pisano E, Joyce J. Digital mammography versus film-screen mammography: technical, clinical and economic assessments. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA) 2002: 55 Authors' objectives The aim of this report is to compare the technical, clinical and potential costs of digital mammography (DM) and film-screen mammography (FSM) within the context of the Canadian health

2002 Health Technology Assessment (HTA) Database.

152. Full-field digital mammography

Full-field digital mammography Full-field digital mammography Full-field digital mammography BlueCross BlueShield Association Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. The BlueCross BlueShield Association Technology Evaluation Center website ( ) includes the most recent 3 years of TEC Assessments. To request older reports, please use the “contact us” feature (...) on the website. Citation BlueCross BlueShield Association. Full-field digital mammography. Chicago: BlueCross BlueShield Association (BCBS). TEC Assessment 17(7). 2002 Authors' objectives This Assessment reviews the evidence comparing full-field digital mammography (FFDM) and screen-film mammography (SFM) for use in two settings: the screening population and the population of patients referred for diagnostic mammography based on initial suspicious findings. Radiation exposure, recall rates, biopsy rates

2002 Health Technology Assessment (HTA) Database.

153. Computer-aided detection (CAD) in mammography

Computer-aided detection (CAD) in mammography Computer-aided detection (CAD) in mammography Computer-aided detection (CAD) in mammography BlueCross BlueShield Association Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. The BlueCross BlueShield Association Technology Evaluation Center website ( ) includes the most recent 3 years of TEC Assessments. To request older (...) reports, please use the “contact us” feature on the website. Citation BlueCross BlueShield Association. Computer-aided detection (CAD) in mammography. Chicago: BlueCross BlueShield Association (BCBS). TEC Assessment 17(17). 2002 Authors' objectives The objective of this Assessment is to evaluate the clinical effectiveness of using computer-aided detection (CAD) as an adjunct to mammography. Project page URL Indexing Status Subject indexing assigned by CRD MeSH Breast Neoplasms /diagnosis; Computers

2002 Health Technology Assessment (HTA) Database.

154. Will screening mammography in the East do more harm than good?

Will screening mammography in the East do more harm than good? Will screening mammography in the East do more harm than good? Will screening mammography in the East do more harm than good? Leung G M, Lam T H, Thach T Q, Hedley A J Authors' objectives To evaluate the effects of white, population-based mammographic screening when applied to a low-risk Chinese population. Searching MEDLINE (January 1966 to October 2000) and the Cochrane Library were searched for potentially relevant studies (...) ; the search terms were reported. To identify additional trials, bibliographies of systematic reviews and clinical practice guidelines were scanned and experts were consulted. Only studies published in the English language were eligible for inclusion; abstracts were excluded. Study selection Study designs of evaluations included in the review Randomised controlled trials (RCTs) were eligible for inclusion in the review. Specific interventions included in the review Studies of population-based mammography

2002 DARE.

155. The effectiveness of interventions to promote mammography among women with historically lower rates of screening.

The effectiveness of interventions to promote mammography among women with historically lower rates of screening. The effectiveness of interventions to promote mammography among women with historically lower rates of screening The effectiveness of interventions to promote mammography among women with historically lower rates of screening Legler J, Meissner HI, Coyne C, Breen N, Chollette V, Rimer B K Authors' objectives To describe mammography intervention research efforts in diverse (...) populations; to determine which intervention characteristics explain variation in intervention effectiveness; and to assess the effectiveness of particular types of interventions and this benefit for specific populations of women with historically lower use of mammography (older women, women with low incomes and non-Caucasian women). Searching A 'parent' database of articles that described screening mammography interventions (see Other Publications of Related Interest no.2) was established from initial

2002 DARE.

156. Surveillance mammography after treatment of primary breast cancer: a systematic review

Surveillance mammography after treatment of primary breast cancer: a systematic review Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2002 DARE.

157. The role of ultrasonography as an adjunct to mammography in the detection of breast cancer: a systematic review

The role of ultrasonography as an adjunct to mammography in the detection of breast cancer: a systematic review The role of ultrasonography as an adjunct to mammography in the detection of breast cancer: a systematic review The role of ultrasonography as an adjunct to mammography in the detection of breast cancer: a systematic review Flobbe K, Nelemans P J, Kessels A G, Beets G L, von Meyenfeldt M F, van Engelshoven J M Authors' objectives To assess the diagnostic value of ultrasonography (...) as an adjunct to mammography in detecting breast cancer. Searching MEDLINE, EMBASE, and the Cochrane Library were searched for studies published between 1990 and 2000; the search terms were not reported. Studies in English, German, French, Italian, or Dutch were eligible for inclusion. The reference lists of selected papers were screened for additional studies. Study selection Study designs of evaluations included in the review The authors did not specify any a priori inclusion criteria relating

2002 DARE.

158. Newspaper reporting of screening mammography. (Abstract)

Newspaper reporting of screening mammography. Continuing controversy surrounds screening mammography, particularly for women 40 to 49 years of age. Newspapers are potentially important sources of information on this topic, but it is not known whether they provide well-founded and objective information and recommendations.To examine how screening mammography is reported in newspapers.Cross-sectional descriptive study.6 top-circulation U.S. newspapers, 1990 to 1997.Number of articles about (...) screening mammography, issues covered by the articles, information sources, content and sources of quotes, recommendations cited in articles, and presentation of risks and benefits.The most common theme of newspaper articles about mammography was screening for women 40 to 49 years of age. Thirty-one percent of the articles presented information without citing a source or justification. Quotes and recommendations in the articles were approximately twice as likely to support as to express reservations

2001 Annals of Internal Medicine

159. Cochrane review on screening for breast cancer with mammography. (Abstract)

Cochrane review on screening for breast cancer with mammography. In 2000, we reported that there is no reliable evidence that screening for breast cancer reduces mortality. As we discuss here, a Cochrane review has now confirmed and strengthened our previous findings. The review also shows that breast-cancer mortality is a misleading outcome measure. Finally, we use data supplemental to those in the Cochrane review to show that screening leads to more aggressive treatment.

2001 Lancet

160. Screening for breast cancer with mammography. (Abstract)

Screening for breast cancer with mammography. Mammographic screening for breast cancer is controversial, as reflected in greatly varying national policies.To assess the effect of screening for breast cancer with mammography on mortality and morbidity.MEDLINE (16 May 2000), The Cochrane Breast Cancer Group's trial register (24 Jan 2000) and reference lists. Letters, abstracts and unpublished trials. Authors were contacted.Randomised trials comparing mammographic screening with no mammographic

2001 Cochrane